Details zur Publikation

Referenztyp Zeitschriften
DOI / URL Link
Titel (primär) The OSIRIS Weight of Evidence approach: ITS for skin sensitisation
Autor Rorije, E.; Aldenberg, T.; Buist, H.; Kroese, D.; Schüürmann, G.;
Journal / Serie Regulatory Toxicology and Pharmacology
Erscheinungsjahr 2013
Department OEC;
Band/Volume 67
Heft 2
Sprache englisch;
POF III (gesamt) T42;
Keywords Integrated Testing Strategy; ITS; REACH; Weight-of-Evidence; WoE; Bayesian inference
UFZ Querschnittsthemen RU3;
Abstract

Within the EU FP6 project OSIRIS approaches to Integrated Testing Strategies (ITSs) were developed, with the aim to facilitate the use of non-test and non-animal testing information in regulatory risk assessment of chemicals. This paper describes an analytical Weight-of-Evidence (WoE) approach to an ITS for the endpoint of skin sensitisation. It specifically addresses the European chemicals legislation REACH, but the concept is readily applicable to ITS and WoE procedures in other regulatory frameworks, and for other toxicological endpoints. Bayesian statistics are applied to estimate the reliability of a conclusion on the sensitisation potential of a chemical, combining evidence from different information sources such as QSAR model predictions, in vitro and in vivo test results. The methodology allows for adaptation of the weight of individual information sources to account for the different levels of reliability of the individual ITS components. The calculated reliability of the WoE conclusion gives an objective, transparent and reproducible measure to decide if the information requirements for data evaluation are satisfied. Furthermore, in case the WoE is not sufficient, it gives the possibility to evaluate a priori if and how it will be possible to fulfil the information requirements with additional tests and/or model predictions.

ID 14264
dauerhafte UFZ-Verlinkung https://www.ufz.de/index.php?en=20939&ufzPublicationIdentifier=14264
Rorije, E., Aldenberg, T., Buist, H., Kroese, D., Schüürmann, G. (2013):
The OSIRIS Weight of Evidence approach: ITS for skin sensitisation
Regul. Toxicol. Pharmacol. 67 (2), 146 - 156